These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 28595561)

  • 1. Sexual Dysfunction, Cardiovascular Risk and Effects of Pharmacotherapy.
    Imprialos KP; Stavropoulos K; Doumas M; Tziomalos K; Karagiannis A; Athyros VG
    Curr Vasc Pharmacol; 2018 Jan; 16(2):130-142. PubMed ID: 28595561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Birds with One Stone: Regular Use of PDE5 Inhibitors for Treating Male Patients with Erectile Dysfunction and Cardiovascular Diseases.
    Cai Z; Zhang J; Li H
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):119-128. PubMed ID: 30675707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual function in hypertensive patients receiving treatment.
    Reffelmann T; Kloner RA
    Vasc Health Risk Manag; 2006; 2(4):447-55. PubMed ID: 17323599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update of the position paper on arterial hypertension and erectile dysfunction.
    Viigimaa M; Vlachopoulos C; Doumas M; Wolf J; Imprialos K; Terentes-Printzios D; Ioakeimidis N; Kotsar A; Kiitam U; Stavropoulos K; Narkiewicz K; Manolis A; Jelakovic B; Lovic D; Kreutz R; Tsioufis K; Mancia G;
    J Hypertens; 2020 Jul; 38(7):1220-1234. PubMed ID: 32073535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sexual activity and the heart].
    Stein R; Hohmann CB
    Arq Bras Cardiol; 2006 Jan; 86(1):61-7. PubMed ID: 16491211
    [No Abstract]   [Full Text] [Related]  

  • 6. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
    Kostis JB; Jackson G; Rosen R; Barrett-Connor E; Billups K; Burnett AL; Carson C; Cheitlin M; Debusk R; Fonseca V; Ganz P; Goldstein I; Guay A; Hatzichristou D; Hollander JE; Hutter A; Katz S; Kloner RA; Mittleman M; Montorsi F; Montorsi P; Nehra A; Sadovsky R; Shabsigh R
    Am J Cardiol; 2005 Jul; 96(2):313-21. PubMed ID: 16018863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatment options for erectile dysfunction in patients with diabetes mellitus.
    Basu A; Ryder RE
    Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
    García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
    J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The safety of 5-phosphodiesterase inhibitors in the treatment of erectile dysfunction in patients with cardiovascular disease].
    Bryniarski L; Rzepecki M; Klocek M; Wyczołkowski M
    Przegl Lek; 2009; 66(4):192-7. PubMed ID: 19708509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease.
    Kapur V; Chien CV; Fuess JE; Schwarz ER
    Rev Cardiovasc Med; 2008; 9(3):187-95. PubMed ID: 18953278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
    Blonde L
    Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.
    Goldstein I; Kim E; Steers WD; Pryor JL; Wilde DW; Natanegara F; Wong DG; Ahuja S
    J Sex Med; 2007 Jan; 4(1):166-175. PubMed ID: 17233782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of erectile dysfunction and peculiarities of its treatment in men with high cardiovascular risk].
    Mamedov MN; Digigova RT; Sharvadze GG; Ugurchieva ZO; Kovrigina MN; Stroeva MV
    Kardiologiia; 2010; 50(11):85-90. PubMed ID: 21526570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?
    Imprialos K; Koutsampasopoulos K; Manolis A; Doumas M
    Curr Vasc Pharmacol; 2021; 19(3):301-312. PubMed ID: 32286949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sex, erectile dysfunction, and the heart: a growing problem].
    Görge G; Flüchter S; Kirstein M; Kunz T
    Herz; 2003 Jun; 28(4):284-90. PubMed ID: 12825143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the association between erectile dysfunction and cardiovascular disease.
    Gandaglia G; Briganti A; Jackson G; Kloner RA; Montorsi F; Montorsi P; Vlachopoulos C
    Eur Urol; 2014 May; 65(5):968-78. PubMed ID: 24011423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs.
    Terentes-Printzios D; Ioakeimidis N; Rokkas K; Vlachopoulos C
    Nat Rev Cardiol; 2022 Jan; 19(1):59-74. PubMed ID: 34331033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk.
    Nehra A; Jackson G; Miner M; Billups KL; Burnett AL; Buvat J; Carson CC; Cunningham GR; Goldstein I; Guay AT; Hackett G; Kloner RA; Kostis J; Montorsi P; Ramsey M; Rosen RC; Sadovsky R; Seftel AD; Vlachopoulos C; Wu FC
    J Urol; 2013 Jun; 189(6):2031-8. PubMed ID: 23313195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of the application of cialis for erectile dysfunction].
    Koroleva SV; Apolikhin OI; Kovalev VA
    Urologiia; 2003; (6):61-4. PubMed ID: 14708250
    [No Abstract]   [Full Text] [Related]  

  • 20. Duration of erection: does it really matter? A randomized, double-blind clinical trial to assess the impact of vardenafil ODT on duration of erection and its correlation with patients' and partners' sexual quality of life and duration of intercourse: the VADEOPEN study.
    Martin-Morales A; Gutiérrez-Hernández P; Romero-Otero J; Romero-Martín JA;
    J Sex Med; 2014 Jun; 11(6):1527-38. PubMed ID: 24628736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.